[Liver cirrhosis as a multisystem disease].

In recent years, the pathophysiological concept of decompensated liver cirrhosis has undergone significant changes. Until a few years ago, the focus of pathophysiological considerations was on the hyperdynamic circulation resulting from portal hypertension. In recent years, emerging data suggests that increased bacterial translocation leading to systemic inflammation plays an important role in patients with decompensated liver cirrhosis. This inflammation affects a variety of extrahepatic organs. Nowadays, liver cirrhosis is considered not only a condition confined to the liver but rather an inflammatory-triggered multisystem disease. The existing inflammation serves as the common pathophysiological explanation for the diverse impact of liver cirrhosis on several extrahepatic organs. It plays a significant role in the development of conditions such as hepatorenal syndrome, cirrhotic cardiomyopathy, hepatopulmonary syndrome, hepatic encephalopathy, and even in the emergence of cirrhosis-associated relative adrenal insufficiency. These new pathophysiological insights hold clinical significance as they influence the prophylaxis and treatment of patients with decompensated liver cirrhosis.
Competing Interests: DB: Vortragstätigkeit: Falk Foundation, W. L. Gore & Associates; Reisesponsering: Gilead Science; Forschungsförderung: Dr. Rolf M. Schwiete-Stiftung MS: Vortragstätigkeit für Falk Foundation e.V., W. L. Gore & Associates, Bentley InnoMed GmbH
(Thieme. All rights reserved.)